此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Hybrid Telerehabilitation for Anterior Knee Pain in Routine Physiotherapy Practice

2026年9月25日 更新者:Farraj Miguel

Integrating Hybrid Telerehabilitation Into Routine Physiotherapy Practice for Anterior Knee Pain: Protocol for a Real-World Pragmatic Mixed-Methods Study

This study will examine how hybrid telerehabilitation is used in routine physiotherapy care for adults with anterior knee pain. Approximately 30 participants will be followed for 72 weeks while receiving individualized treatment from their physiotherapist, supported by the moveUP mobile application. The application provides prescribed exercises, educational information, communication with the physiotherapist, and progress monitoring.

The study will assess adherence to rehabilitation, pain, knee function, quality of life, psychological factors, and physical activity. It will also explore whether patient adherence and physiotherapist engagement are associated with clinical outcomes. Interviews with patients and healthcare professionals will examine barriers and facilitators to using the platform in routine care.

研究概览

地位

招聘中

研究类型

介入性

注册 (估计的)

30

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

      • Brussels、比利时
        • 招聘中
        • Private clinics
        • 接触:
      • Paris、法国
        • 招聘中
        • Private clinics
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Age 18 years or older.
  • Clinical diagnosis of anterior knee pain, including patellofemoral pain, patellar tendinopathy, Hoffa's fat pad syndrome, chondromalacia, or femoropatellar, tibiopatellar, or tibiofemoral osteoarthritis not requiring surgery.
  • Access to a smartphone compatible with the moveUP application.

Exclusion Criteria:

  • Currently awaiting spine or lower-limb surgery.
  • Lower-limb surgery or other invasive intervention within the previous two years.
  • Joint prosthesis.
  • Acute trauma to the trunk or lower limbs, or fracture, dislocation, or other musculoskeletal pathology of the affected lower limb within the previous six months.
  • Saphenous nerve neuritis or Ehlers-Danlos syndrome.
  • Severe osteoarthritis requiring joint replacement, systemic inflammatory joint disease (including rheumatoid arthritis or gout), or joint infection.
  • Persistent low back pain lasting three months or longer.
  • Vascular, respiratory, or neurological conditions that interfere with participation.
  • Cognitive or psychiatric impairment limiting application use or communication.
  • Pregnancy.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Hybrid Telerehabilitation

Participants receive individualized physiotherapy for anterior knee pain supported by the moveUP mobile application over 72 weeks. Treatment is prescribed and adapted by the treating physiotherapist according to individual patient needs.

Hybrid telerehabilitation combining routine physiotherapy with the moveUP mobile application for adults with anterior knee pain. The platform supports individualized exercise prescription, educational modules, patient-physiotherapist communication, and progress monitoring. Exercise selection, frequency, and progression are determined by the treating physiotherapist according to patient needs. Participants are followed for 72 weeks.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Exercise Adherence (ATEMPT Score)
大体时间:Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

Exercise adherence will be assessed using the Adherence to Exercise for Musculoskeletal Pain Tool (ATEMPT). Total scores range from 6 to 30, with higher scores indicating greater adherence.

Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
Pain Intensity (Visual Analog Scale)
大体时间:Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

Pain intensity will be measured using a 0-100 mm Visual Analog Scale (VAS), where 0 indicates no pain and 100 indicates the worst pain imaginable. Higher scores indicate greater pain intensity.

Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

次要结果测量

结果测量
措施说明
大体时间
Knee Function (Anterior Knee Pain Scale)
大体时间:aseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

The Anterior Knee Pain Scale assesses symptoms and functional limitations associated with anterior knee pain. The total score ranges from 0 to 100, with higher scores indicating better function and fewer symptoms

aseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
Health-Related Quality of Life (EQ-5D)
大体时间:Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. Responses will be converted into a utility index using the Belgian value set. Scores range from -0.532 to 1, with higher scores indicating better health-related quality of life.

Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
Fear of Movement (Tampa Scale for Kinesiophobia)
大体时间:Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

The 11-item Tampa Scale for Kinesiophobia assesses fear of movement or reinjury. The total score ranges from 11 to 44, with higher scores indicating greater kinesiophobia and therefore a worse outcome

Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
Pain Catastrophizing (Pain Catastrophizing Scale)
大体时间:Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

The Pain Catastrophizing Scale is a 13-item questionnaire assessing catastrophic thoughts related to pain. The total score ranges from 0 to 52, with higher scores indicating greater pain catastrophizing and therefore a worse outcome

Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
Physical Activity (Daily Step Count)
大体时间:Daily/weekly
Daily/weekly

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年9月1日

初级完成 (估计的)

2028年5月1日

研究完成 (估计的)

2028年12月1日

研究注册日期

首次提交

2026年9月21日

首先提交符合 QC 标准的

2026年9月21日

首次发布 (实际的)

2026年9月25日

研究记录更新

最后更新发布 (实际的)

2026年9月30日

上次提交的符合 QC 标准的更新

2026年9月25日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他研究编号

  • AIM2-AKP-001
  • 2024-RDIR-5c (其他赠款/资助编号:Innoviris)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅